Stocks to Watch on March 17: IndusInd Bank, Infosys, Brigade Enterprises and more
IndusInd Bank remains financially stable, with strong capital adequacy (16.46%) and liquidity ratios (LCR of 113%), as confirmed by the RBI. Infosys’ subsidiary, Infosys McCamish, reached a settlement agreement in the US for $17.5 million to resolve six class action lawsuits related to a cyber incident. Brigade Enterprises launched its new residential project, Brigade Eternia, in Yelahanka, Bengaluru, with an estimated revenue potential of ₹2,700 crore, along with a premium project in Devanahalli. Zydus Lifesciences successfully completed a USFDA inspection at its Ankleshwar facility with zero observations, affirming its adherence to regulatory standards. Shilpa Medicare’s subsidiary also passed a USFDA inspection at its Raichur facility with no observations, marking its second consecutive clean inspection.
